Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taurine for the Prevention and Treatment of Radiation-induced Oral Mucositis in Patients With Nasopharyngeal Carcinoma
NCT07567742Phase 2Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- May 2026
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of taurine in oral mucositis (OM) (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Incidence of Severe Radiation-Induced Oral Mucositis up to 11 weeks. Started May 2026; status: recruiting.
02
Drugs
taurine
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT07567742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07567742.